Narrow search
Showing 1 - 9 of 9
Cover Image
The effect of GDP growth on pharmaceutical patent protection, 1945 - 2005
La Croix, Sumner J.; Liu, Ming - In: Brussels economic review 52 (2009) 3/4, pp. 355-375
Persistent link: https://www.econbiz.de/10009238416
Cover Image
The impact of stronger property rights in pharmaceuticals on innovation in developed and developing countries
Liu, Ming; La Croix, Sumner J. - 2011
Persistent link: https://www.econbiz.de/10009503531
Cover Image
A cross-country index of intellectual property rights in pharmaceutical innovations
Liu, Ming; La Croix, Sumner J. - 2013
Persistent link: https://www.econbiz.de/10010233927
Cover Image
A cross-country index of intellectual property rights in pharmaceutical innovations
Liu, Ming; La Croix, Sumner J. - 2014
Persistent link: https://www.econbiz.de/10010378905
Cover Image
The impact of stronger property rights in pharmaceuticals on innovation in developed and developing countries
Liu, Ming; La Croix, Sumner J. - 2014
Persistent link: https://www.econbiz.de/10010378908
Cover Image
A cross-country index of intellectual property rights in pharmaceutical inventions
Liu, Ming; La Croix, Sumner J. - In: Research policy : policy, management and economic … 44 (2015) 1, pp. 206-216
Persistent link: https://www.econbiz.de/10011317950
Cover Image
Logistics planning for hospital pharmacy trusteeship under a hybrid of uncertainties
Liu, Ming; Zhang, Zhe; Zhang, Ding - In: Transportation research / E : an international journal 101 (2017), pp. 201-215
Persistent link: https://www.econbiz.de/10011701900
Cover Image
Patents and access to essential medicines
La Croix, Sumner J.; Liu, Ming - In: Intellectual property, growth and trade, (pp. 423-464). 2008
Persistent link: https://www.econbiz.de/10003684914
Cover Image
Chapter 13 Patents and Access to Essential Medicines
La Croix, Sumner; Liu, Ming - In: Intellectual property, growth and trade, (pp. 423-464). 2007
The World Health Organization estimated that in 1999 roughly one-third of the world's population lacked access to essential medicines that would have saved or improved their lives. Our analysis focuses on how pharmaceutical product patents restrict access to essential medicines in developing...
Persistent link: https://www.econbiz.de/10015383964